Fig. 1From: Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLDA Chemical structures of silybin A (left) and silybin B (right); B transmission electron microscopy images of (a) lipid-polymer hybrid nanoparticles (LPNs), (b) silymarin-loaded LPNs (S-LPNs), and (c) chitosan-modified S-LPNs (CS-LPNs)Back to article page